Therapeutic targeting of the TPX2/TTK network in colorectal cancer.

Shaath, Hibah; Vishnubalaji, Radhakrishnan; Elango, Ramesh; Velayutham, Dinesh; Jithesh, Puthen Veettil; Alajez, Nehad M

Shaath, Hibah; Vishnubalaji, Radhakrishnan; Elango, Ramesh; Velayutham, Dinesh; Jithesh, Puthen Veettil; Alajez, Nehad M.

Affiliation

Shaath H; Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, 00000, Doha, Qatar.
Vishnubalaji R; Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, 00000, Doha, Qatar.
Elango R; Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, 00000, Doha, Qatar.
Velayutham D; College of Health & Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
Jithesh PV; College of Health & Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
Alajez NM; Translational Cancer and Immunity Center (TCIC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, 00000, Doha, Qatar. nalajez@hbku.edu.qa.

Cell Commun Signal ; 21(1): 265, 2023 09 28.

Article in En | MEDLINE | ID: mdl-37770979

Subject(s)
Key words

Colorectal cancer; DDX39A; Gene-drug-interaction; LRP8; Precision medicine; TPX2; TTK

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenocarcinoma / Colonic Neoplasms Limits: Humans Language: En Journal: Cell Commun Signal Year: 2023 Document type: Article Affiliation country: Qatar

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google